Alnylam Pharmaceuticals
ALNY
#1123
Rank
โ‚น1.971 T
Marketcap
โ‚น14,718
Share price
3.61%
Change (1 day)
-62.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company